Volume of transfusion (units) (PPT) (during hospital stay) · orthopaedic (spinal)
1 finding from 1 review
Mortality (up to 90 days) ‐ not reported · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All DVT · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection (up to 90 days) · orthopaedic (spinal)
Cell salvage showed no clear difference in infection (up to 90 days) compared with no cell salvage (low certainty).
1 finding from 1 review
MI (up to 90 days) ‐ not reported · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion · orthopaedic (mixed)
It is very uncertain whether cell salvage changes transfusions (during hospital stay) compared with no cell salvage (very low certainty).
1 finding from 1 review
Volume of transfusion (units) (PPT) (during hospital stay) · orthopaedic (mixed)
1 finding from 1 review
Mortality (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
MI (up to 90 days) ‐ not reported · cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deep vein thrombosis · orthopaedic (mixed)
Cell salvage showed no clear difference in DVT (up to 90 days) compared with no cell salvage (low certainty).
1 finding from 1 review
Infection (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes infection (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
MI (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes MI (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
Stroke · orthopaedic (mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion · cardiovascular (vascular) surgeries
It is very uncertain whether cell salvage changes transfusions (during hospital stay) compared with no cell salvage (very low certainty).
1 finding from 1 review
Volume of transfusion (units) (PPT) (during hospital stay) · cardiovascular (vascular) surgeries
1 finding from 1 review
50% or greater reduction in seizure frequency · people with drug‐resistant focal epilepsy
Summary of findings: lamotrigine probably leads to higher 50% or greater reduction in seizure frequency (ITT analysis) compared with placebo (moderate certainty).
1 finding from 1 review
Treatment withdrawal · people with drug‐resistant focal epilepsy
Summary of findings: lamotrigine showed no clear difference in treatment withdrawal compared with placebo (moderate certainty).
1 finding from 1 review
Ataxia · people with drug‐resistant focal epilepsy
Summary of findings: lamotrigine probably leads to higher ataxia compared with placebo (moderate certainty).
1 finding from 1 review